Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Podcast
Today, we take you behind the scenes of something rare: a tour inside Incyte’s research labs in Wilmington, Delaware, followed by the Patient Advocacy Summit.
Day One (September 4, 2025) felt almost cinematic — community leaders walking the same halls as scientists, asking everything from “What does it take to become a scientist?” to “How do you decide which molecule deserves millions in investment?”
No staged press moments, just real dialogue about the alchemy of discovery, where 400,000 compounds can be narrowed down to one therapy like Opzelura.
Day Two (September 5, 2025) shifted to strategy and policy. Advocates sat across from Incyte’s executive team, pressing on real-world issues: access, safety, pediatric use, adherence, and what it means to be the first mover while competitors close in. The conversations spanned treatment motivation, behavioral economics, insurance battles, and even research linking vitiligo to industrial pollutants.
At the heart of it all was the human element — the faces behind the data, the advocates shaping the agenda, and the scientists listening and learning from lived experience.
The big takeaway? Progress in vitiligo happens when patients and researchers sit at the same table — not as bystanders, but as true partners.
Dig deeper for more details:
FAQOther Questions
- Who is prone to vitiligo?
Vitiligo can affect anyone, regardless of gender, age, or race. Vitiligo prevalence is between 0.76% and 1.11% of the U.S. population, including around 40% of those with the con...
- What is the best therapy for localized vitiligo?
Localized vitiligo, where the white patches are limited to one or a few areas of the body, can be managed with a few treatment approaches. The best therapy usually depends on th...
- Isn't it just a cosmetic disorder?
Contrary to popular belief, vitiligo is not merely a cosmetic issue but a complex autoimmune disorder that affects the body’s largest organ—along with other vital systems—and is...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.